Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Curr Radiopharm. 2011 Apr 1;4(2):131–139. doi: 10.2174/1874471011104020131

Fig. (3).

Fig. (3)

Multimodality imaging of PSMA with 89Zr-J591. (A) Cerenkov luminescence imaging of tumor-bearing mice injected with 89Zr-J591 in a small animal optical scanner. (B) Corresponding coronal and transverse immunoPET images of the mouse. The signal originates from the LNCaP tumors (PSMA-positive). Mouse bearing two different sized tumors of the same origin was used to demonstrate that differential uptake between the small and large tumors can be discerned by Cerenkov luminescence imaging. Adapted from [43].